|
CAS-Nr. | 379231-04-6 |
Bezeichnung: | |
Englisch Name: | Saracatinib |
Synonyma: | saracatinib;AZD0530 difuMarate;AZD0530(Saracatinib);Saracatinib (AZD0530);4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline;N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;7-[2-[4-Methylpiperazin-1-yl]ethoxy]-5-[[tetrahydropyran-4-yl]oxy]-4-[[6-chloro-2,3-Methylenedioxyphenyl]aMino]quinazoline;N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine;N-(5-Chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine;4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1-piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)- |
CBNumber: | CB61518531 |
Summenformel: | C27H32ClN5O5 |
Molgewicht: | 542.03 |
MOL-Datei: | 379231-04-6.mol |
|
|
|
|
Saracatinib physikalisch-chemischer Eigenschaften |
|
Saracatinib Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften White Solid |
|
Verwenden An oral, selective dual inhibitor of Src and ABL kinase. |
|
|
Saracatinib Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
Saracatinib Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 62)Lieferanten |
|
|
|
|
379231-04-6(Saracatinib)Verwandte Suche: |
Methyl-4-hydroxybenzoat
1-Methylpiperazin
2-Ethoxyphenol
Basic Violet 1
Diethoxymethylacetat
Diethoxymethan
Ethoxychin
Paraquat-dichlorid
Dasatinib monohydrate
Ethoxymethylenmalononitril
Chlordifluormethan
Acetonitril
Gefitinib
Sunitinib
Lapatinib
Imatinib
Ethylenglykolmonoethylether
Kresoxim-methyl
|
379231-04-6
saracatinib
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine
C27H32ClN5O5
APIs
4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline
4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1-piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
N-(5-Chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
Saracatinib (AZD0530)
Aromatics
Heterocycles
Intermediates & Fine Chemicals
Pharmaceuticals
Protein Kinase Inhibitors and Activators
AZD0530(Saracatinib)
AZD0530 difuMarate
7-[2-[4-Methylpiperazin-1-yl]ethoxy]-5-[[tetrahydropyran-4-yl]oxy]-4-[[6-chloro-2,3-Methylenedioxyphenyl]aMino]quinazoline
(S)-2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetaMide
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine Saracatinib (AZD0530)
Saracatinib N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine
|
Urheberrecht 2009 © ChemicalBook. Alle Rechte vorbehalten. |